Jonathan Mark Hopper
CIK 1626325 · Chief Medical Officer · last filed 2026-06-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.00M
Companies
2
Total Filings
35
Lifetime Open-Market Net
-$6.26M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VCEL | Chief Medical Officer | 80,128 | $37.46 | $3.00M | -$6.26M | 33 | 2026-06-04 |
| OSIRIS THERAPEUTICS, INC. (OSIR) Delisted | Chief Medical Officer | — | — | — | $0 | 2 | 2016-04-15 |
Recent Filings · Page 4 of 4
35 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-08 | VCEL | Mixed | +386 | -$12.5K | EDGAR |
| 2020-12-23 | VCEL | Mixed | +19,029 | -$169.4K | EDGAR |
| 2020-02-13 | VCEL | Grant (A) | — | $0 | EDGAR |
| 2016-04-15 | OSIRIS THERAPEUTICS, INC. (OSIR) Delisted | Disp (D) | — | $0 | EDGAR |
| 2016-04-14 | OSIRIS THERAPEUTICS, INC. (OSIR) Delisted | Disp (D) | — | $0 | EDGAR |
Showing 31–35 of 35
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.